首页> 外文期刊>Biological research: BR >Tumor suppressive function of Matrin 3 in the basal-like breast cancer
【24h】

Tumor suppressive function of Matrin 3 in the basal-like breast cancer

机译:基质乳腺癌中基质3的肿瘤抑制函数

获取原文
           

摘要

Basal-like breast cancer (BLBC) or triple-negative breast cancer (TNBC) is an aggressive and highly metastatic subtype of human breast cancer. The present study aimed to elucidate the potential tumor-suppressive function of MATR3, an abundant nuclear protein, in BLBC/TNBC, whose cancer-relevance has not been characterized. We analyzed in vitro tumorigenecity by cell proliferation and soft agar colony formation assays, apoptotic cell death by flow cytometry and Poly (ADP-ribose) polymerase (PARP) cleavage, epithelial-mesenchymal transition (EMT) by checking specific EMT markers with real-time quantitative PCR and in vitro migration and invasion by Boyden Chamber assays. To elucidate the underlying mechanism by which MATR3 functions as a tumor suppressor, we performed Tandem affinity purification followed by mass spectrometry (TAP-MS) and pathway analysis. We also scrutinized MATR3 expression levels in the different subtypes of human breast cancer and the correlation between MATR3 expression and patient survival by bioinformatic analyses of publicly available transcriptome datasets. MATR3 suppressed in vitro tumorigenecity, promoted apoptotic cell death and inhibited EMT, migration, and invasion in BLBC/TNBC cells. Various proteins regulating apoptosis were identified as MATR3-binding proteins, and YAP/TAZ pathway was suppressed by MATR3. MATR3 expression was inversely correlated with the aggressive and metastatic nature of breast cancer. Moreover, high expression levels of MATR3 were associated with a good prognosis of breast cancer patients. Our data demonstrate that MATR3 functions as a putative tumor suppressor in BLBC/TNBC cells. Also, MATR3 potentially plays a role as a biomarker in predicting chemotherapy-sensitivity and patient survival in breast cancer patients.
机译:基础乳腺癌(BLBC)或三阴性乳腺癌(TNBC)是人乳腺癌的侵略性和高转移性亚型。目前的研究旨在阐明Gry3,Bubc / TNBC中的核蛋白质的潜在肿瘤抑制功能,其癌症相关性尚未表征。通过细胞增殖和软琼脂菌落形成测定,通过流式细胞术和聚(ADP-核糖)聚合酶(PARP)裂解,通过检查特定EMT标记,通过实时检查特定EMT标记,通过细胞增殖和软琼脂菌落形成测定,凋亡细胞死亡,凋亡细胞死亡,通过检查特定的EMT标记,通过检查特定的EMT标记Boyden室测定的定量PCR和体外迁移和侵袭。为了阐明MOT3作为肿瘤抑制剂的潜在机制,我们进行了串联亲和纯化,然后进行了质谱(TAP-MS)和途径分析。我们还通过公开的转录组数据集的生物信息分析扰乱了人乳腺癌的不同亚型中的MOT3表达水平和MOT3表达和患者存活之间的相关性。 MOTR3抑制了体外肿瘤性,促进了凋亡细胞死亡并抑制了BLBC / TNBC细胞中的EMT,迁移和侵袭。将各种蛋白质调节细胞凋亡被鉴定为MOTR3结合蛋白,并通过MOTR3抑制YAP / TAZ途径。与乳腺癌的侵袭性和转移性,matr3表达与乳腺癌的激进和转移性相关。此外,MOTR3的高表达水平与乳腺癌患者的良好预后有关。我们的数据表明,MOT3在BLBC / TNBC细胞中用作推定的肿瘤抑制剂。此外,MITR3可能在乳腺癌患者中预测化疗敏感性和患者存活中的生物标志物中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号